Navigation Links
Inflammation may link obesity and adverse pregnancy outcomes
Date:1/10/2012

erides. Increased maternal body mass index is associated with an increased risk of neonatal early onset group B streptococcal disease, and an increased risk of respiratory tract infections. The inflammatory response and immune function of the newborn might relate to later health outcomes. Hyper-responsiveness of inflammatory function at birth is linked to the development of allergic disease in infancy.

Maternal metabolic status during pregnancy and weaning is particularly relevant to healthy development of hypothalamic neurones that regulate weight and feeding in offspring, the researchers report. One study demonstrated that a high-fat diet during pregnancy can induce the expression of hypothalamic peptides involved in the regulation of food intake and body composition in weanling rats. More recently, female offspring of fathers fed a chronic high fat diet had impaired glucose tolerance and insulin secretion. "These findings lead to the suggestion that such programmed expression has a role to play in adult physiology, including increased food intake, preference for a fat-rich diet, weight gain, and metabolic dysfunction," says Dr. Thornton.

"Diseases once found only in adults are increasing in the paediatric population. The focus has been on diseases with a clear metabolic component and it remains relatively unknown what risk maternal obesity during pregnancy imposes for the development of autoimmune diseases, allergy and asthma, and neurodevelopment and cognitive behavior," stated Dr. Thornton. "Animal models indicate that the provision of a normal diet to the offspring once weaned does not overcome the effects of maternal overnutrition, so simple dietary changes may prove ineffective. Targeted maternal immunomodulation might be needed to curtail this potential pandemic."


'/>"/>
Contact: Daphne Watrin
d.watrin@iospress.nl
31-206-883-355
IOS Press
Source:Eurekalert

Page: 1 2

Related biology news :

1. Novel technique uses RNA interference to block inflammation
2. Blocking inflammation could lead to tailored medical treatments
3. Pitt team finds molecular pathway that leads to inflammation in asthma
4. Blocking common gateway to inflammation suppresses cancer
5. Researchers see a picture of threat in the brain: Work may lead to new model of neuroinflammation
6. BUSM awarded NIH grant to identify role of immune system in chronic inflammation, disease
7. Scientists discover that a specific enzyme inhibitor may help control lung inflammation
8. Study on effects of resveratrol and quercetin on inflammation and insulin resistance
9. BUSM researchers uncover cellular mechanism responsible for chronic inflammation, Type 2 diabetes
10. Researchers discover how natural drug fights inflammation
11. Barrow scientists uncover clues on inflammation in central nervous system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... de julio de 2015 La 10 th ... por medio de BGI del 22 al 25 de octubre de ... Este año, la conferencia celebra su décimo aniversario. Desde ... en una de las reuniones anuales más influyentes del mundo ... reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... regularly vomiting hairballs or refusing to eat probably isn,t being ... There is a good chance that the cat is acting ... environment, new research suggests. Healthy cats were just as ... and leave waste outside their litter box in response to ...
... Salt Lake City, December 30, 2010Officials at Huntsman ... that the National Cancer Institute (NCI) has renewed its ... recognizes the outstanding cancer research conducted at HCI, which ... West and is the only NCI-designated Cancer Center within ...
... can result in long waiting times for seriously ill ... illnesses for the next available treatment. In this edition ... Int 2010; 107[50]: 892𔃆), Michael Christ and his ... assessment of emergency patients. Triage provides reliable methods ...
Cached Biology News:Even healthy cats act sick when their routine is disrupted 2Even healthy cats act sick when their routine is disrupted 3Even healthy cats act sick when their routine is disrupted 4Even healthy cats act sick when their routine is disrupted 5National Cancer Institute renews Cancer Center designation for Huntsman Cancer Institute 2
(Date:9/2/2015)... 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Nanobiotechnology Applications, ... An increasing use of ... is anticipated. Nanotechnology will be applied at ... formulations for optimal delivery to diagnostic applications ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... , September 2, 2015 BiondVax Pharmaceuticals ... the National Institute of Allergy and Infectious Diseases (NIAID), part ... Department of Health and Human Services (HHS), to launch a ... the United States in the 2015-16 timeframe. The ... candidate, Multimeric-001 (M-001), as a primer vaccine, which would be ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... SHANGHAI, June 21 /PRNewswire-Asia/ -- WuXi ... pharmaceutical, biotechnology, and medical device research and,development outsourcing company ... that Wei-Min Chang has been appointed Vice President of,Operations ... located in the Jinshan chemical industry zone of Shanghai. ...
... Inc. announced on June 16, 2009, that the Company ... each filed a voluntary petition for reorganization under chapter ... United States Bankruptcy Court for the District of Delaware ... to continue to manage and operate their business as ...
... Corp. (TSX, FSE: HBP) today announced that Dr. Heman ... be presenting a scientific poster describing L-DOS47 analytical method ... Scientists ("AAPS") National Biotechnology Conference, which runs from June ... Trade Center in Seattle, Washington. , ...
Cached Biology Technology:WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 2Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 4Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 5
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: